fr

CARMAT announces the first commercial implants of its Aeson® artificial heart outside the European Union

Two cardiology experts join CARMAT’s Board of Directors as independent members

Download

Update on the PIVOTAL study on the CARMAT bioprosthetic artificial heart

Download

2016 half-year results

Download

Stéphane Piat has been appointed CEO of CARMAT

Download

CARMAT announces the departure of Marcello Conviti, CEO

Download

CARMAT announces the start of the PIVOTAL study

Download

CARMAT has obtained the necessary approvals to begin the PIVOTAL study in France

Download

Extraordinary General Meeting of August 10, 2016

Download
Top of page